Long-Term Outcomes of Intervention Versus Conservative Management in Symptomatic Cerebral Cavernous Malformations: Insights from a Population-Based Cohort Study
Posted inNeurology news

Long-Term Outcomes of Intervention Versus Conservative Management in Symptomatic Cerebral Cavernous Malformations: Insights from a Population-Based Cohort Study

A prospective cohort study reveals that surgical or radiosurgical intervention for symptomatic cerebral cavernous malformations is linked with increased risks of severe functional impairment or death over long-term follow-up, underscoring the need for randomized controlled trials.
Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology: Insights from Large Cohort Studies
Posted inClinical Updates Neurology news OB/GYN & Women's Health

Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology: Insights from Large Cohort Studies

This review synthesizes recent evidence linking menopausal hormone therapy (MHT), particularly estrogen-only regimens, with decreased Alzheimer disease neuropathology and clinical dementia risk, highlighting biomarker correlations, clinical outcomes, and implications for therapeutic strategies in postmenopausal women.
Neurological Effects and Safety of Encapsulated Dexamethasone Sodium Phosphate in Pediatric Ataxia Telangiectasia: Insights from the NEAT Phase 3 Trial
Posted inClinical Updates Neurology news Pediatrics

Neurological Effects and Safety of Encapsulated Dexamethasone Sodium Phosphate in Pediatric Ataxia Telangiectasia: Insights from the NEAT Phase 3 Trial

The NEAT phase 3 trial evaluated erythrocyte-encapsulated dexamethasone sodium phosphate in children with ataxia telangiectasia aged 6–9 years, confirming safety but failing to demonstrate statistically significant neurological improvement over placebo.